Abstract

COMPLIANCE WITH INTERNATIONAL GUIDELINE FOR THE MANAGEMENT OF PNEUMONIA IN ICU

Atasi Barman*¹, Dr. sushmita Basu², Dr. K.Kuotsu¹

ABSTRACT

Hospital-acquired pneumonia (HAP) is defined as pneumonia that occurs at least forty-eight hours after hospital admission and the designation of ventilator-associated pneumonia (VAP) is given to those patients that develop pneumonia greater than 48–72 hours after endotracheal intubation. HAP extends total hospital length of stay by 30% and seven to nine days on an average. Approximately 1% of hospitalized patients are affected by HAP and this infectious process increases total healthcare costs by more than 1 lakh rupee. The major goals of this study is the management of HAP & VAP according to the evidence based guidelines and emphasize early, appropriate antibiotics in adequate doses, while avoiding excessive antibiotics by deescalation of initial antibiotic therapy. Our study was set up in a 12 bedded territory care hospital situated in Kolkata, West Bengal, India. The total number of patient in ICU 618 from those patients, 12 patients had nosocomial pneumonia all were suffering from HAP but no one were suffering from VAP in a period of nine months. It was found that out of 618 patients 12 patients (1.94%) were suffering from HAP. It can be say that in the age group of 40-80 years they are more prone to grow nosocomial pneumonia rather than other age groups. In my study It was found that form 618 patients 354 (57.28%) male patients and form that 7 (1.97%) were suffering from HAP and 264 (42.72%) were female patients and form that 5 (1.89%) were suffering from HAP there was a clear male preponderance. In my study comorbidities in case of male like HTN were 5, DM were 5, COPD was 1 so total comorbidities were 11 and in case of female HTN were 4, DM were 4, IHD was 1, Asthma was 1, thus total co-morbidities were 10 .

Keywords: HAP, nosocomial pneumonia, co-morbidities.